Primary Site >> Liver Cancer

Gene >> TPO

  • 1998
  • 2000
  • 2003
  • 2004
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
Ref: Thrombopoietin in patients with hepatoblastoma.
PMID: 9766812
Ref: Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma.
PMID: 11787473
Ref: Thrombopoietin-producing hepatocellular carcinoma.
PMID: 12924502
Ref: Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
PMID: 15300887
Ref: Effects of thrombopoietin on growth of hepatocellular carcinoma: Is thrombopoietin therapy for liver disease safe or not?
PMID: 23157389
Ref: Usefulness of short-term eltrombopag treatment as a supportive treatment in hepatocellular carcinoma patients with cirrhosis and severe thrombocytopenia: A report of two cases.
PMID: 24932302
Ref: Deficiency in thrombopoietin induction after liver surgery is associated with postoperative liver dysfunction.
PMID: 25611592
Ref: TPO-Induced Metabolic Reprogramming Drives Liver Metastasis of Colorectal Cancer CD110+ Tumor-Initiating Cells.
PMID: 26140605
Ref: Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma.
PMID: 26270232
Ref: The Eltrombopag antitumor effect on hepatocellular carcinoma.
PMID: 26397763
Ref: Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan.
PMID: 26925204
Ref: Blood DNA methylation markers in potentially identified Chinese patients with hepatocellular carcinoma.
PMID: 27592479
Ref: Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection.
PMID: 29085203